raloxifene hydrochloride has been researched along with lovastatin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alonso, M; Alonso, R; Cerrato, F; Fernández-Suárez, ME; Gómez-Coronado, D; Lasunción, MA; Mata, P; Pastor, O; Vázquez, C | 1 |
1 other study(ies) available for raloxifene hydrochloride and lovastatin
Article | Year |
---|---|
Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes.
Topics: Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Hep G2 Cells; Hepatocytes; Humans; Lipoproteins, LDL; Lovastatin; Lymphocytes; Male; Raloxifene Hydrochloride; Receptors, LDL; Selective Estrogen Receptor Modulators; Structure-Activity Relationship; Tamoxifen; Toremifene | 2015 |